Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Core Laboratories Inc (NYSE: CLB) closed the day trading at $12.79 down -0.85% from the previous closing price of $12.9. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 0.34 million shares were traded. CLB stock price reached its highest trading level at $12.97 during the session, while it also had its lowest trading level at $12.63.
Ratios:
For a better understanding of CLB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.83. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 2.21. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on March 12, 2025, Upgraded its rating to Neutral and sets its target price to $16 from $15 previously.
On June 30, 2023, Citigroup Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $22 to $21.
BofA Securities Downgraded its Neutral to Underperform on April 18, 2023, while the target price for the stock was maintained at $21.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLB now has a Market Capitalization of 599632320 and an Enterprise Value of 703954432. As of this moment, Core’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.81, and their Forward P/E ratio for the next fiscal year is 15.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.16 while its Price-to-Book (P/B) ratio in mrq is 2.36. Its current Enterprise Value per Revenue stands at 1.36 whereas that against EBITDA is 10.858.
Stock Price History:
The Beta on a monthly basis for CLB is 1.41, which has changed by -0.36901826 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, CLB has reached a high of $25.13, while it has fallen to a 52-week low of $10.14. The 50-Day Moving Average of the stock is 9.36%, while the 200-Day Moving Average is calculated to be -20.45%.
Shares Statistics:
Over the past 3-months, CLB traded about 574.87K shares per day on average, while over the past 10 days, CLB traded about 757410 shares per day. A total of 46.70M shares are outstanding, with a floating share count of 46.36M. Insiders hold about 1.12% of the company’s shares, while institutions hold 113.86% stake in the company. Shares short for CLB as of 1749772800 were 7857828 with a Short Ratio of 13.67, compared to 1747267200 on 7784529. Therefore, it implies a Short% of Shares Outstanding of 7857828 and a Short% of Float of 44.759998.
Dividends & Splits
CLB’s forward annual dividend rate is 0.04, up from 0.04 a year ago. Against a Trailing Annual Dividend Yield of 0.0031007752The stock’s 5-year Average Dividend Yield is 0.47. The current Payout Ratio is 5.97% for CLB, which recently paid a dividend on 2025-05-05 with an ex-dividend date of 1746403200. Stock splits for the company last occurred on 2010-07-09 when the company split stock in a 2:1 ratio.
